Steve Engle is an experienced executive and board member in the biotechnology industry. Steve has served on the boards of several companies, including Averigon, BayBio, Biotechnology, and Prescient Therapeutics. Steve was also the chairman and CEO of XOMA from 2007 to 2011.
Engle currently serves as an independent, non-executive director at Aroa Biosurgery. Steve also served on the board of Anthera Pharmaceuticals from 2014 to 2017.
Steve Engle graduated from The University of Texas at Austin with a Master's in Electrical Engineering and a Bachelor's in Biomedical Engineering.